Chinese Biopharmaceutical Association-Usa Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 40,416 | 62,410 | −21,994 | 116.3 | 0% |
| 2021 | 140,026 | 31,264 | 108,762 | 273.9 | 0% |
| 2022 | 68,050 | 82,255 | −14,205 | 102.0 | 0% |
| 2023 | 123,294 | 141,241 | −17,947 | 57.9 | 0% |
In its most recent public year (2023), this organization spent $17,947 more than it brought in. Its reserves stood at about 57.9 months of spending, down from 116.3 in 2020. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works